FDA Inspection 904618 — NAMSA
The FDA completed an inspection of NAMSA on June 11, 2014 in Chasse-Sur-Rhone. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 11, 2014
- Fiscal Year
- 2014
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Chasse-Sur-Rhone (France)